Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Sethuraman Natarajan Chief Scientific Officer Grant or award +28,400 190,544
2023-03-01 Sethuraman Natarajan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +43,000 43,000
2023-03-01 Doshi Dipal President and CEO Grant or award +99,300 261,135
2023-03-01 Doshi Dipal President and CEO Grant or award · Stock Option (Right to Buy) +150,500 150,500
2023-03-01 Dowden Nathan J Chief Operating Officer Grant or award +28,400 73,683
2023-03-01 Dowden Nathan J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +43,000 43,000
2023-03-01 KREHER NERISSA Chief Medical Officer Grant or award +28,400 43,916
2023-03-01 KREHER NERISSA Chief Medical Officer Grant or award · Stock Option (Right to Buy) +43,000 43,000
2023-02-28 Doshi Dipal President and CEO Sale −2,000 $12.00 $24K 161,835
2023-01-27 Doshi Dipal President and CEO Sale −2,000 $12.00 $24K 163,835
2023-01-09 Doshi Dipal President and CEO Sale −2,410 $15.02 $36K 165,835
2022-12-30 KREHER NERISSA Chief Medical Officer Sale −5,200 $13.45 $70K 15,516
2022-12-29 Doshi Dipal President and CEO Sale −400 $15.01 $6K 168,245
2022-12-28 Doshi Dipal President and CEO Sale −4,521 $15.01 $68K 168,645
2022-12-27 Doshi Dipal President and CEO Sale −600 $14.80 $9K 182,235
2022-12-27 Doshi Dipal President and CEO Sale −9,069 $15.04 $136K 173,166
2022-12-08 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +4,550 $2.10 $10K 21,059
2022-12-08 WENTWORTH KORY JAMES Chief Financial Officer Sale −4,550 $18.95 $86K 16,509
2022-12-08 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) −4,550 100,947
2022-12-05 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +200 $2.10 $420 16,709

Page 18 of 26 · 517 trades